ProfileGDS5822 / ILMN_2476329
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 74% 77% 73% 77% 74% 76% 71% 68% 71% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 174.674
GSM1276600PDAC Late Ablation Control 2113.277
GSM1276601PDAC Late Ablation Control 396.773
GSM1276602PDAC Late Ablation 195.477
GSM1276603PDAC Late Ablation 286.274
GSM1276604PDAC Late Ablation 3102.176
GSM1303940PDAC Late Ablation_anti-CTLA4 153.471
GSM1303941PDAC Late Ablation_anti-CTLA4 257.968
GSM1303942PDAC Late Ablation_anti-CTLA4 376.671